Medicare Enrolled

Dr. Jesus Perez, MD

Endocrinology · Sarasota, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
943 S BENEVA RD STE 210, Sarasota, FL 34232
9413791777
In practice since 2006 (20 years)
NPI: 1639142961 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Perez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Perez

Dr. Jesus Perez is an endocrinology specialist in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Perez performed 153,364 Medicare services across 11,945 unique beneficiaries.

Between the years covered by Open Payments, Dr. Perez received a total of $289,744 from 34 pharmaceutical and/or device companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Perez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in FL $289,744 industry payments

Florida License Status

FL DOH · MQA
2
Active licenses
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Certified Nursing Assistant 246888 Clear May 31, 2028
Medical Doctor 86942 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
153,364
Medicare services
Top 0% in FL for endocrinology
11,945
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,668 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Romosozumab injection (Evenity) for osteoporosis 66,570 $8 $19
Testosterone injection 48,200 $0 $0
Denosumab injection (Prolia/Xgeva) 21,120 $18 $42
Office visit, established patient (30-39 min) 2,614 $90 $218
Blood draw (venipuncture) 2,141 $8 $14
Hemoglobin A1c test (diabetes monitoring) 1,190 $10 $28
Free thyroxine (T4) test 1,147 $9 $25
Thyroid stimulating hormone (TSH) test 1,147 $16 $48
Blood creatinine level 909 $5 $15
Bone density scan (DEXA) 895 $36 $201
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 888 $26 $89
Blood glucose (sugar) level 886 $4 $12
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 666 $55 $158
Urine microalbumin test (kidney screening) 602 $6 $14
Creatinine test (kidney function) 602 $5 $14
Vitamin D level test 597 $29 $81
Chronic care management, first 20 min/month 397 $48 $86
Calcium level, total 370 $5 $15
Drug injection, under skin or into muscle 287 $10 $51
New patient office visit (45-59 min) 235 $117 $334
Parathyroid hormone level test 216 $40 $113
Basic metabolic blood panel 212 $8 $24
Office visit, established patient (20-29 min) 166 $63 $150
Fine needle aspiration biopsy using ultrasound guidance, first growth 117 $100 $261
Thyroid hormone, t3 measurement, free 110 $17 $45
Chronic care management, additional 20 min/month 109 $36 $69
Comprehensive metabolic blood panel 107 $10 $30
Complete blood count (CBC) with differential 105 $8 $22
Lipid panel (cholesterol and triglycerides) 93 $13 $38
Magnesium level test 91 $7 $18
Phosphate level test 88 $5 $14
Fine needle aspiration biopsy using ultrasound guidance, each additional growth 71 $48 $124
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 50 $17 $45
Urinalysis with microscopic exam 34 $3 $9
Red blood cell concentration measurement 33 $2 $7
Blood count, hemoglobin 33 $2 $7
Prostate cancer screening; prostate specific antigen test (psa) 27 $19 $51
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) 26 $48 $127
Office visit, established patient, complex (40-54 min) 24 $124 $294
Vitamin B-12 level test 21 $14 $43
Kidney function blood test panel 19 $9 $25
New patient office visit, complex (60-74 min) 18 $158 $421
Ferritin level test (iron stores) 17 $13 $39
Iron level test 17 $6 $18
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin 16 $46 $108
Telephone medical discussion with physician, 11-20 minutes 16 $66 $150
Automated urinalysis 15 $2 $7
Albumin (protein) level 13 $5 $12
Iron binding capacity test 13 $9 $24
PSA test (prostate cancer screening) 12 $18 $53
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment 12 $109 $323
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$289,744
Total received (2018-2024)
Avg $41,392/year across 7 years
Top 4% in FL for endocrinology
34
Companies
389
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$275,124 (95.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,127 (3.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,494 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$37,833
2023
$31,104
2022
$24,391
2021
$30,891
2020
$30,075
2019
$91,023
2018
$44,428

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$166,715
Novo Nordisk Inc
$89,597
Merck Sharp & Dohme Corporation
$9,291
Lilly USA, LLC
$6,412
Ascendis Pharma Inc
$6,202
Corcept Therapeutics
$4,010
Horizon Therapeutics plc
$2,938
Medtronic MiniMed, Inc.
$1,302
Alexion Pharmaceuticals, Inc.
$725
BIOTRONIK INC.
$615
Clarus Therapeutics Inc.
$500
Radius Health, Inc.
$299
Tandem Diabetes Care, Inc.
$131
Mannkind Corporation
$125
Xeris Pharmaceuticals, Inc.
$115
Bayer HealthCare Pharmaceuticals Inc.
$110
Shire North American Group Inc
$71
Insulet Corporation
$70
RECORDATI_RARE_DISEASES_INC.
$60
Dexcom, Inc.
$57
SANOFI-AVENTIS U.S. LLC
$53
Ipsen Biopharmaceuticals, Inc
$50
Abbott Laboratories
$48
Baylis Medical Technologies Inc.
$34
LifeScan, Inc.
$33
Rhythm Pharmaceuticals, Inc.
$33
Medtronic, Inc.
$31
Antares Pharma, Inc.
$20
Valeritas, Inc.
$19
MannKind Corporation
$18
Kyowa Kirin, Inc.
$17
Boston Scientific Corporation
$17
BETA BIONICS, INC.
$15
Siemens Medical Solutions USA, Inc.
$15
Top 3 companies account for 91.7% of total payments
Associated products mentioned in payments ›
AFREZZA · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · EVENITY · Enbrel · FORTEO · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · JARDIANCE · JATENZO · Kerendia · Korlym · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 530G · Minimed 630G · Minimed 670G System · NAEOTOM Alpha · Omnipod · OneTouch · Ozempic · Prolia · RYBELSUS · Rybelsus · SOMATULINE DEPOT · STEGLATRO · STRENSIQ · Saxenda · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tresiba · Tymlos · V-GO · Varithena Administration Pack · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for endocrinology in FL.

Equivalent to $189 per 100 Medicare services performed
Looking for an endocrinology specialist in Sarasota?
Compare endocrinologists in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
24
Per 100K population
5.3
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Perez is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with speaking/promotional industry engagement in the top 4% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Perez experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Perez performed 66,570 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perez receive payments from pharmaceutical companies?
Yes. Dr. Perez received a total of $289,744 from 34 companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perez's costs compare to other endocrinologists in Sarasota?
Dr. Perez's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →